Science & Enterprise subscription

Follow us on Twitter

  • A smartphone app is being developed to help pregnant women and new mothers with an opioid addiction, by a medical p… https://t.co/6YA7lUJnMu
    about 1 hour ago
  • New post on Science and Enterprise: App Created for New, Pregnant Moms in Opioid Recovery https://t.co/Zu5igRQQwk #Science #Business
    about 1 hour ago
  • A start-up company spun-off from Cornell University is receiving a small business grant to develop in crop plants a… https://t.co/oU7iBAy0Uo
    about 21 hours ago
  • New post on Science and Enterprise: NSF Funding Natural Agri-Chemical Technology https://t.co/YYyhF8LKw2 #Science #Business
    about 21 hours ago
  • An assessment of a closed-loop insulin pump system shows a sizeable proportion of first-time users stopped using it… https://t.co/IEIvQzQDtG
    about 1 day ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Challenge Seeks Development Partner for Nanotech Biosensor

EKG (Photos8.com)

(Photos8.com)

20 June 2014. A new challenge on InnoCentive calls for a medical technology company or institute to develop a new type of nanoscale biosensor for diagnostic and therapeutic applications. The challenge has no immediate financial award, but winners of the competition will earn the right to negotiate a compensated collaboration contract with the Cleveland Clinic, the challenge’s sponsor, to develop their ideas.

The deadline for submissions is 2 August 2014; a free registration is required to see the challenge details.

InnoCentive in Waltham, Massachusetts conducts open-innovation, crowdsourcing competitions for corporate and organization sponsors, in this case the Cleveland Clinic. InnoCentive calls this type of competition an an electronic request for partners challenge, where competitors submit a written proposal for evaluation and follow-up by the sponsor.

The Cleveland Clinic is currently developing an invasive biosensor based on a new kind of nanotechnology for use in diagnosis and therapies that they hope will help clinicians and medical technicians do their work more safely and with more reliable outcomes. The clinic says the new device is expected to be a unique innovation and a significant improvement over current diagnostic technologies.

In this challenge, Cleveland Clinic is seeking an organizational partner that can take its design for the biosensor and develop it into a workable product. Collaborators are expected to provide biotechnical engineering, computer expertise, and nanotechnology production services, as well as the initial funding for the work.

Participants in the challenge are expected to submit a written preliminary proposal for review by Cleveland Clinic staff. Competitors are urged not to reveal confidential information in their proposals. Winning entrants will then negotiate a collaboration contract with Cleveland Clinic.

The collaboration contract will cover the scope of the work and tasks to be performed, as well as milestones, timetable, and financial terms. While participation in the challenge does not require any transfer of intellectual property, the issue will also likely be a subject of the contract negotiations and document.

Read more:

*     *     *

Please share Science & Enterprise ...

Comments are closed.